Giovanni Carone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giovanni Carone has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Perin
Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
5 shared publications - Torstein Ragnar Meling
Department of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark
5 shared publications - Francesco DiMeco
Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
4 shared publications - Chiara Benedetta Rui
Neurosurgery, Fondazione IRCCS San Gerardo dei Tintori, Via Pergolesi 33, 20900 Monza, Italy
3 shared publications - Enrico Gambatesa
Department of Neurosurgery, Fondazione I.R.C.C.S. Istituto Neurologico "C. Besta", Milano, Italy
3 shared publications - Tommaso Francesco Galbiati
Neurosurgical Department, IRCCS Istituto Ortopedico Galeazzi, Milan, Lombardia, Italy
3 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by Elsevier in Brain and Spine
- Vol. 6, 107457
Implementing a multimodal simulation-based curriculum in a neurosurgery residency program: The University of Milan experience
- 25 September 2026
- Published by Elsevier in Brain and Spine
- Vol. 6, 107457
Open AccessImplementing a multimodal simulation-based curriculum in a neurosurgery residency program: The University of Milan experience
- Open Access
- 14 July 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (11) , 2637-2649
Focused ultrasound-mediated blood-brain barrier opening reshapes plasma extracellular vesicle size distribution without elevating concentration in glioblastoma patients
Background: Focused ultrasound-mediated blood-brain barrier opening (FUS-BBBO) is hypothesized to enhance liquid biopsy by facilitating the release of tumor material into the circulation. This study aimed to evaluate the impact of MR-guided FUS-BBBO on plasma extracellular vesicle (EV) concentrations and size distributions, alongside cell-free DNA (cfDNA) profiles, to determine the clinical efficacy of this approach in glioblastoma (GB) patients. Methods: We performed 14 MR-guided FUS-BBBO procedures in patients with GB with blood sampling 1 h before and 1 h after sonication. Plasma EVs were isolated by size-exclusion chromatography and quantified by tunable resistive pulse sensing technology. cfDNA concentration and fragment profiles were assessed using fluorometric and electrophoretic methods. Results: EV concentration showed no consistent change after FUS-BBBO, with marked inter-patient and inter-procedure heterogeneity. In contrast, EV size displayed a reproducible diameter reduction of ∼8-10 nm, driven predominantly by contraction of the upper tail of the size distribution, indicating selective modulation of larger vesicle subpopulations. cfDNA concentrations and fragmentation showed a heterogeneous pattern, with occasional patient-specific increases. Exploratory analyses revealed no significant associations between biomarker changes and procedural parameters except for treated volume. Conclusions: Our findings challenge the assumption that clinical BBBO uniformly increases biomarker abundance. The consistent shift toward smaller EVs suggests a selective modulation rather than an increased release. While BBBO may enhance the detectability of analytes that poorly cross the BBB, this may not apply to EVs, which are able to traverse the BBB under physiological conditions, further supporting their value as liquid-biopsy substrates in neuro-oncology. Future studies integrating clinical data with mechanistic models are necessary to refine FUS-enhanced diagnostic strategies.
- 14 July 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (11) , 2637-2649
Open AccessFocused ultrasound-mediated blood-brain barrier opening reshapes plasma extracellular vesicle size distribution without elevating concentration in glioblastoma patients
Background: Focused ultrasound-mediated blood-brain barrier opening (FUS-BBBO) is hypothesized to enhance liquid biopsy by facilitating the release of tumor material into the circulation. This study aimed to evaluate the impact of MR-guided FUS-BBBO on plasma extracellular vesicle (EV) concentrations and size distributions, alongside cell-free DNA (cfDNA) profiles, to determine the clinical efficacy of this approach in glioblastoma (GB) patients. Methods: We performed 14 MR-guided FUS-BBBO procedures in patients with GB with blood sampling 1 h before and 1 h after sonication. Plasma EVs were isolated by size-exclusion chromatography and quantified by tunable resistive pulse sensing technology. cfDNA concentration and fragment profiles were assessed using fluorometric and electrophoretic methods. Results: EV concentration showed no consistent change after FUS-BBBO, with marked inter-patient and inter-procedure heterogeneity. In contrast, EV size displayed a reproducible diameter reduction of ∼8-10 nm, driven predominantly by contraction of the upper tail of the size distribution, indicating selective modulation of larger vesicle subpopulations. cfDNA concentrations and fragmentation showed a heterogeneous pattern, with occasional patient-specific increases. Exploratory analyses revealed no significant associations between biomarker changes and procedural parameters except for treated volume. Conclusions: Our findings challenge the assumption that clinical BBBO uniformly increases biomarker abundance. The consistent shift toward smaller EVs suggests a selective modulation rather than an increased release. While BBBO may enhance the detectability of analytes that poorly cross the BBB, this may not apply to EVs, which are able to traverse the BBB under physiological conditions, further supporting their value as liquid-biopsy substrates in neuro-oncology. Future studies integrating clinical data with mechanistic models are necessary to refine FUS-enhanced diagnostic strategies.
- Open Access
- 30 August 2024
- Published by Elsevier in Brain and Spine
- Vol. 4, 102923
Non-technical skills for neurosurgeons: An international survey
- 30 August 2024
- Published by Elsevier in Brain and Spine
- Vol. 4, 102923
Open AccessNon-technical skills for neurosurgeons: An international survey
- Open Access
- 11 May 2024
- Published by Elsevier in Brain and Spine
- Vol. 4, 102829
Simulation to become a better neurosurgeon. An international prospective controlled trial: The Passion study
- 11 May 2024
- Published by Elsevier in Brain and Spine
- Vol. 4, 102829
Open AccessSimulation to become a better neurosurgeon. An international prospective controlled trial: The Passion study
- Open Access
Fluorescence and Intraoperative Ultrasound as Surgical Adjuncts for Brain Metastases Resection: What Do We Know? A Systematic Review of the Literature
(1) Background: brain metastases (BMs) are the most common neoplasm of the central nervous system; despite the high incidence of this type of tumour, to date there is no universal consensus on the most effective treatment in patients with BMs, even if surgery still plays a primary role. Despite this, the adjunct systems that help to reach the GTR, which are well structured for other tumour forms such as ultrasound and fluorescence systems, are not yet well employed and standardised in surgical practice. The aim of this review is to provide a picture of the current state-of-art of the roles of iOUS and intraoperative fluorescence to better understand their potential roles as surgical tools. (2) Methods: to reach this goal, the PubMed database was searched using the following string as the keyword: (((Brain cerebral metastasis [MeSH Major Topic])OR (brain metastasis, [MeSH Major Topic])) AND ((5-ala, [MeSH Terms]) OR (Aminolevulinicacid [All fields]) OR (fluorescein, [MeSH Terms]) OR (contrast enhanced ultrasound [MeSH Terms])OR ((intraoperative ultrasound. [MeSH Terms]))) AND (english [Filter]) AND ((english [Filter]) AND (2010:2022 [pdat])) AND (english [Filter]). (3) Results: from our research, a total of 661 articles emerged; of these, 57 were selected. 21 of these included BMs generically as a secondary class for comparisons with gliomas, without going deeply into specific details. Therefore, for our purposes, 36 articles were considered. (4) Conclusions: with regard to BMs treatment and their surgical adjuncts, there is still much to be explored. This is mainly related to the heterogeneity of patients, the primary tumour histology and the extent of systemic disease; regardless, surgery plays a paramount role in obtaining a local disease control, and more standardised surgical protocols need to be made, with the aim of optimizing the use of the available surgical adjuncts and in order to increase the rate of GTR.
Open AccessFluorescence and Intraoperative Ultrasound as Surgical Adjuncts for Brain Metastases Resection: What Do We Know? A Systematic Review of the Literature
(1) Background: brain metastases (BMs) are the most common neoplasm of the central nervous system; despite the high incidence of this type of tumour, to date there is no universal consensus on the most effective treatment in patients with BMs, even if surgery still plays a primary role. Despite this, the adjunct systems that help to reach the GTR, which are well structured for other tumour forms such as ultrasound and fluorescence systems, are not yet well employed and standardised in surgical practice. The aim of this review is to provide a picture of the current state-of-art of the roles of iOUS and intraoperative fluorescence to better understand their potential roles as surgical tools. (2) Methods: to reach this goal, the PubMed database was searched using the following string as the keyword: (((Brain cerebral metastasis [MeSH Major Topic])OR (brain metastasis, [MeSH Major Topic])) AND ((5-ala, [MeSH Terms]) OR (Aminolevulinicacid [All fields]) OR (fluorescein, [MeSH Terms]) OR (contrast enhanced ultrasound [MeSH Terms])OR ((intraoperative ultrasound. [MeSH Terms]))) AND (english [Filter]) AND ((english [Filter]) AND (2010:2022 [pdat])) AND (english [Filter]). (3) Results: from our research, a total of 661 articles emerged; of these, 57 were selected. 21 of these included BMs generically as a secondary class for comparisons with gliomas, without going deeply into specific details. Therefore, for our purposes, 36 articles were considered. (4) Conclusions: with regard to BMs treatment and their surgical adjuncts, there is still much to be explored. This is mainly related to the heterogeneity of patients, the primary tumour histology and the extent of systemic disease; regardless, surgery plays a paramount role in obtaining a local disease control, and more standardised surgical protocols need to be made, with the aim of optimizing the use of the available surgical adjuncts and in order to increase the rate of GTR.
- 1 October 2021
- Published by Elsevier in World Neurosurgery
- Vol. 154, e130-e146
The “STARS-CASCADE” Study: Virtual Reality Simulation as a New Training Approach in Vascular Neurosurgery
- 1 October 2021
- Published by Elsevier in World Neurosurgery
- Vol. 154, e130-e146
The “STARS-CASCADE” Study: Virtual Reality Simulation as a New Training Approach in Vascular Neurosurgery
- 1 October 2021
- Published by Elsevier in World Neurosurgery
- Vol. 154, e19-e28
The “STARS–CT-MADE” Study: Advanced Rehearsal and Intraoperative Navigation for Skull Base Tumors
- 1 October 2021
- Published by Elsevier in World Neurosurgery
- Vol. 154, e19-e28
The “STARS–CT-MADE” Study: Advanced Rehearsal and Intraoperative Navigation for Skull Base Tumors